Abstract

Olfactory dysfunction is a major non-motor symptom that appears during the early stages of Parkinson’s Disease (PD), a neurodegenerative disorder characterized by loss of dopaminergic neurons in the substantia nigra (SN). Depletion of SN dopaminergic neurons by 6-hydroxydopamine (6-OHDA) is widely used as a model for PD and ultimately results in motor deficits. However, it is largely unknown whether olfactory behavior and, more importantly, neural activity in the olfactory bulb (OB) are impaired prior to the appearance of motor deficits. We partially depleted the SN dopaminergic population in mice by injection of 6-OHDA. Seven days after injection of 6-OHDA, motor ability was unchanged but olfactory-driven behaviors were significantly impaired. Injection of 6-OHDA into the SN significantly increased the power of the ongoing local field potential in the OB for all frequency bands, and decreased odor-evoked excitatory beta responses and inhibitory high-gamma responses. Moreover, 6-OHDA treatment led to increased odor-evoked calcium responses in the mitral cells in the OB of awake mice. These data suggest that the olfactory deficits caused by depletion of the SN dopaminergic population are likely due to abnormal hyperactivity of the mitral cells in the OB.

Highlights

  • Parkinson’s disease (PD) is a neurodegenerative disorder characterized by massive loss of dopaminergic neurons in the substantia nigra (SN) and subsequent dopamine depletion in the striatum, a critical structure for motor control

  • Since the olfactory bulb (OB) glomerular layer contains a substantial population of dopaminergic neurons, application of 6-OHDA into the SN might lesion these dopaminergic neurons in the OB in addition to the dopaminergic neurons in the SN

  • To confirm that dopaminergic neurons were selectively depleted only in the SN and not in the OB, we counted the number of dopaminergic neurons in the OB glomerular layer seven days after injection of 6-OHDA into the SN (Fig. 1c)

Read more

Summary

Introduction

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by massive loss of dopaminergic neurons in the substantia nigra (SN) and subsequent dopamine depletion in the striatum, a critical structure for motor control. On the seventh day after 6-OHDA injection, the motor ability of the mice was unchanged but there was neural hyperactivity in the OB and olfactory-driven behaviors were significantly impaired. Similar to the results for 2–12 Hz, injection of 6-OHDA significantly increased the power in both the 2–8 Hz and 8–13 Hz frequency bands of the ongoing LFP across all the mice recorded (F(1,84) = 6.79, P = 0.011 for 2–8 Hz; F(1,84) = 10.07, P = 0.002 for 8–13 Hz).

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.